Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk.
Low bone mineral density (BMD) is correlated with increased fracture risk. Whether greater BMD increases induced by osteoporosis drugs are related to greater decreases in fracture risk is controversial. We analyzed the relationship between BMD change and fracture risk in postmenopausal osteoporotic...
Main Authors: | Watts, N, Cooper, C, Lindsay, R, Eastell, R, Manhart, MD, Barton, I, van Staa, T, Adachi, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|
Similar Items
-
Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
by: Watts, N, et al.
Published: (2004) -
Risk of Fracture and Bone Mineral Density in Stroke Response
by: Pouwels, S, et al.
Published: (2010) -
VERTEBRAL FRACTURE RISK REDUCTION IS INDEPENDENT OF THE MAGNITUDE OF BMD CHANGE
by: Adachi, J, et al.
Published: (2004) -
Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.
by: Bradbury, L, et al.
Published: (2012) -
Bone mineral density and fracture risk in patients with rheumatic diseases
by: O. V. Dobrovolskaya, et al.
Published: (2020-07-01)